
Johnson & Johnson leads 2026 defensive stocks with 35% gain, outpacing Coca-Cola and Procter & Gamble.
In 2026, among defensive stocks, Johnson & Johnson outperformed with a 35% gain driven by strong oncology and immunology sales and a robust pipeline. Coca-Cola followed with a 28% rise, benefiting from steady global volume and pricing power, while Pr...


